The company is not selling any securities under this prospectus and will not receive any of the proceeds from the sale of shares by the selling stockholder.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACXP:
- Acurx Pharmaceuticals’ Earnings Call: Progress Amidst Funding Challenges
- Acurx assumed with a Buy at H.C. Wainwright
- Acurx Pharmaceuticals: Promising Antibiotic Developments and Strong Financial Position Justify Buy Rating
- Acurx Pharmaceuticals Reports Improved Q1 2025 Results
- Acurx Pharmaceuticals Enters $12M Stock Purchase Agreement
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue